Anti-LAMA4/ CMD1JJ/ LAMA3*-1 functional antibody

Anti-LAMA4/ CMD1JJ/ LAMA3*-1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LAMA4/LAMA4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0298-Ab-1/ GM-Tg-hg-SE0298-Ab-2Anti-Human LAMA4 monoclonal antibodyHuman
GM-Tg-rg-SE0298-Ab-1/ GM-Tg-rg-SE0298-Ab-2Anti-Rat LAMA4 monoclonal antibodyRat
GM-Tg-mg-SE0298-Ab-1/ GM-Tg-mg-SE0298-Ab-2Anti-Mouse LAMA4 monoclonal antibodyMouse
GM-Tg-cynog-SE0298-Ab-1/ GM-Tg-cynog-SE0298-Ab-2Anti-Cynomolgus/ Rhesus macaque LAMA4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0298-Ab-1/ GM-Tg-felg-SE0298-Ab-2Anti-Feline LAMA4 monoclonal antibodyFeline
GM-Tg-cang-SE0298-Ab-1/ GM-Tg-cang-SE0298-Ab-2Anti-Canine LAMA4 monoclonal antibodyCanine
GM-Tg-bovg-SE0298-Ab-1/ GM-Tg-bovg-SE0298-Ab-2Anti-Bovine LAMA4 monoclonal antibodyBovine
GM-Tg-equg-SE0298-Ab-1/ GM-Tg-equg-SE0298-Ab-2Anti-Equine LAMA4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0298-Ab-1/ GM-Tg-hg-SE0298-Ab-2; GM-Tg-rg-SE0298-Ab-1/ GM-Tg-rg-SE0298-Ab-2;
GM-Tg-mg-SE0298-Ab-1/ GM-Tg-mg-SE0298-Ab-2; GM-Tg-cynog-SE0298-Ab-1/ GM-Tg-cynog-SE0298-Ab-2;
GM-Tg-felg-SE0298-Ab-1/ GM-Tg-felg-SE0298-Ab-2; GM-Tg-cang-SE0298-Ab-1/ GM-Tg-cang-SE0298-Ab-2;
GM-Tg-bovg-SE0298-Ab-1/ GM-Tg-bovg-SE0298-Ab-2; GM-Tg-equg-SE0298-Ab-1/ GM-Tg-equg-SE0298-Ab-2
Products NameAnti-LAMA4 monoclonal antibody
Formatmab
Target NameLAMA4
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LAMA4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0298-Ag-1Recombinant multi-species LAMA4/ CMD1JJ/ LAMA3*-1 protein
    ORF Viral VectorpGMLP002644human LAMA4 Lentivirus plasmid
    ORF Viral VectorvGMLP002644human LAMA4 Lentivirus particle


    Target information

    Target IDGM-SE0298
    Target NameLAMA4
    Gene ID3910,16775,309816,696685,475034,101086907,529670,100066875
    Gene Symbol and SynonymsCMD1JJ,LAMA3,LAMA4,LAMA4*-1,RGD1560062
    Uniprot AccessionQ16363
    Uniprot Entry NameLAMA4_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112769
    Target ClassificationN/A

    The target: LAMA4, gene name: LAMA4, also named as CMD1JJ, LAMA3*-1, LAMA4. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.